Biohaven Ltd.
BHVN
$15.61
$0.936.34%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.73% | -71.82% | -107.37% | -73.15% | -73.31% |
| Total Depreciation and Amortization | 27.03% | 29.01% | 13.64% | 35.92% | 62.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -67.90% | 167.71% | 432.76% | 90.49% | 77.73% |
| Change in Net Operating Assets | 891.15% | -121.58% | -31.70% | -56.36% | 75.04% |
| Cash from Operations | -34.36% | -80.80% | -75.58% | -80.18% | -63.87% |
| Capital Expenditure | 73.49% | -47.84% | -32.84% | -55.32% | 17.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -200.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -630.81% | -165.56% | -281.31% | -23.04% | 97.78% |
| Cash from Investing | -242.59% | -169.20% | -288.69% | -23.75% | 95.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -36.85% | 172.03% | 174.82% | 127.48% | 100.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 82.47% | 90.71% | 87.62% | -98.69% | -110.76% |
| Cash from Financing | 13.83% | 257.63% | 219.84% | 30.85% | -20.17% |
| Foreign Exchange rate Adjustments | 119.56% | 120.08% | 115.09% | -233.47% | -228.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -281.63% | -2,202.32% | -1,671.86% | -150.92% | -77.32% |